Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy

Por Mandel, Silvia A., Morelli, Micaela, Halperin, Ilan, Korczyn, Amos D.
Publicado em 2010

A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A

Por Fishman-Jacob, Tali, Reznichenko, Lydia, Youdim, Moussa B. H., Mandel, Silvia A.
Publicado em 2009

Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases

Por Halperin, Ilan, Morelli, Micaela, Korczyn, Amos D., Youdim, Moussa B. H., Mandel, Silvia A.
Publicado no Neurotherapeutics (2009)

A molecular signature in blood identifies early Parkinson’s disease

Por Molochnikov, Leonid, Rabey, Jose M, Dobronevsky, Evgenya, Bonuccelli, Ubaldo, Ceravolo, Roberto, Frosini, Daniela, Grünblatt, Edna, Riederer, Peter, Jacob, Christian, Aharon-Peretz, Judith, Bashenko, Yulia, Youdim, Moussa BH, Mandel, Silvia A
Publicado em 2012

PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

Por Zheng, Bin, Liao, Zhixiang, Locascio, Joseph J., Lesniak, Kristen A., Roderick, Sarah S., Watt, Marla L., Eklund, Aron C., Zhang-James, Yanli, Kim, Peter D., Hauser, Michael A., Grünblatt, Edna, Moran, Linda B., Mandel, Silvia A., Riederer, Peter, Miller, Renee M., Federoff, Howard J., Wüllner, Ullrich, Papapetropoulos, Spyridon, Youdim, Moussa B., Cantuti-Castelvetri, Ippolita, Young, Anne B., Vance, Jeffery M., Davis, Richard L., Hedreen, John C., Adler, Charles H., Beach, Thomas G., Graeber, Manuel B., Middleton, Frank A., Rochet, Jean-Christophe, Scherzer, Clemens R.
Publicado em 2010